Approximately four in 10 cancer cases worldwide may be preventable, according to a new report.An estimated 7.1 million of the 18.7 million global cancer diagnoses in 2022 — equating to 37.9% — could ...

The FDA approved Scancell's phase 3 trial of iSCIB1+ for advanced melanoma, focusing on progression-free survival as a ...

Natco Pharma receives USFDA approval for Erdafitinib, a generic cancer drug for advanced urothelial carcinoma patients.

Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...

Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...

Paul Madley, 66, said he doesn't know 'where he would be' without a 'life-saving' cancer treatment, which has now been ...

By John Vandermosten, CFA NASDAQ:CRDF READ THE FULL CRDF RESEARCH REPORT On January 27th, 2026, Cardiff Oncology, Inc.

In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...

Discover the latest advancements in pancreatic cancer treatment, including targeted therapies and next-generation sequencing, transforming patient care and outcomes.

As we reported here last month, new federal guidelines recommend that women ages 30 to 65 can skip pap smears and do an HPV ...

To help reduce the misuse and misunderstanding of current science, scientific research needs to be explained in language the public can understand.

Vaccination is one of the greatest achievements in immunology and medicine, nearly eradicating many infectious diseases that ...